Science & Technologies

UCB is an R&D driven company, investing over 21% of sales in R&D every year. Research is the lifeblood of UCB's future and is vital to the organisation.

The strength of our science and technologies is based on:

a strong understanding of selected therapeutic areas and disease targets
a novel and entrepreneurial use of discovery technologies for the development of breakthrough medicines
embracing innovation in drug development to push the boundaries of R&D.

Fundamental to our philosophy is connecting science in new ways, notably chemistry and biology, to leverage the potential of these two disciplines.

Key technologies used in UCB R %2526D:

SLAM (Selected Lymphocyte Antibody Method)
Antibody Technology
Gene-To-Drug Research
A2HitTM (Antibody to Hit)
Hit Discovery
Computer Assisted Drug Discovery
Multi-Column Chromatography
SV2A research
Genomics Technology